A Novel Necroptosis-Associated lncRNA Signature Can Impact the Immune Status and Predict the Outcome of Breast Cancer

Figure 6

Kaplan-Meier assays in patients (high and low groups) sequenced according to different clinical-pathological ingredients: (a, b) age; (c, d) stage; (e, f) T stage; (g, h) N stage; (i, j) M stage.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)